Oncolytics Biotech Inc Share Price Today: Live Updates & Key Insights

Oncolytics Biotech Inc share price today is $0.9697, up -2.95%. The stock opened at $0.9785 against the previous close of $0.9789, with an intraday high of $0.9961 and low of $0.9401.

Oncolytics Biotech Inc Share Price Chart

Oncolytics Biotech Inc

us-stock
To Invest in {{usstockname}}
us-stock

Oncolytics Biotech Inc Share Price Performance

$0.9697 -0.0295(-2.95%) ONCY at 23 Mar 2026 02:36 PM Biotechnology
Lowest Today 0.9401
Highest Today 0.9961
Today’s Open 0.9785
Prev. Close 0.9789
52 Week High 1.51
52 Week Low 0.33
Day’s Range: Low 0.9401 High 0.9961
52-Week Range: Low 0.33 High 1.51
1 day return -
1 Week return -4.81
1 month return -10.14
3 month return -1.68
6 month return -26.04
1 year return +54.19
3 year return -21.19
5 year return -68.68
10 year return -

Oncolytics Biotech Inc Institutional Holdings

Morgan Stanley - Brokerage Accounts 0.36

Marshall Wace Asset Management Ltd 0.24

SEEDS INVESTOR LLC 0.24

The Goldman Sachs Group Inc 0.19

International Assets Investment Management, LLC 0.19

Connective Capital Management LLC 0.14

Tocqueville Asset Management L.P. 0.07

CIBC World Markets Inc. 0.07

Franklin Resources Inc 0.06

Royal Bank of Canada 0.06

Fidelity Nasdaq Composite Index 0.06

Geode Capital Management, LLC 0.06

Atlantic Trust Group, LLC 0.05

Head & Associates, LLC 0.04

FINANCIAL ADVISORY CORP /UT/ /ADV 0.04

LPL Financial Corp 0.04

Badgley Phelps Wealth Managers, LLC 0.04

Bank of Montreal 0.04

BMO Capital Markets Corp. 0.04

Commonwealth Equity Services Inc 0.03

Ground Swell Capital, LLC 0.03

Oncolytics Biotech Inc Market Status

Strong Buy: 1

Buy: 4

Hold: 1

Sell: 0

Strong Sell: 0

Oncolytics Biotech Inc Fundamentals

Market Cap 102.23 M

PB Ratio 1236.2692

PE Ratio 0.0

Enterprise Value 95.15 M

Total Assets 20.19 M

Volume 540790

Oncolytics Biotech Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-32357000 -32.4M, FY22:-24835000 -24.8M, FY21:-26304279 -26.3M, FY20:-19551108 -19.6M, FY19:-45552419 -45.6M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-98000 -0.1M

Quarterly Net worth Q3/2025:-14400000 -14.4M, Q2/2025:-6165000 -6.2M, Q1/2025:-6687000 -6.7M, Q3/2024:-9543000 -9.5M, Q2/2024:-7256000 -7.3M

About Oncolytics Biotech Inc & investment objective

Company Information Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.

Organisation Biotechnology

Employees 28

Industry Biotechnology

CEO Mr. Jared Kelly J.D., L.L.M.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Oncolytics Biotech Inc FAQs

What is the share price of Oncolytics Biotech Inc today?

The current share price of Oncolytics Biotech Inc is $0.9697.

Can I buy Oncolytics Biotech Inc shares in India?

Yes, Indian investors can buy Oncolytics Biotech Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Oncolytics Biotech Inc shares in India?

You can easily invest in Oncolytics Biotech Inc shares from India by:

Can I buy fractional shares of Oncolytics Biotech Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Oncolytics Biotech Inc?

Oncolytics Biotech Inc has a market cap of $102.23 M.

In which sector does Oncolytics Biotech Inc belong?

Oncolytics Biotech Inc operates in the Biotechnology sector.

What documents are required to invest in Oncolytics Biotech Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Oncolytics Biotech Inc?

The PE ratio of Oncolytics Biotech Inc is N/A and the PB ratio is 1236.27.